| 4.715 0.105 (2.28%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.57  |
1-year : | 6.5 |
| Resists | First : | 4.76 |
Second : | 5.57 |
| Pivot price | 4.16 |
|||
| Supports | First : | 4.11 |
Second : | 3.71 |
| MAs | MA(5) : | 4.37 |
MA(20) : | 4.09 |
| MA(100) : | 5.86  |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 87.1 |
D(3) : | 78.8 |
| RSI | RSI(14): 61.3 |
|||
| 52-week | High : | 12.94 | Low : | 3.71 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AMWL ] has closed above the upper band by 11.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 21.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.77 - 4.79 | 4.79 - 4.8 |
| Low: | 4.55 - 4.56 | 4.56 - 4.58 |
| Close: | 4.68 - 4.71 | 4.71 - 4.74 |
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Thu, 11 Dec 2025
American Well Corporation (NYSE:AMWL) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Thu, 06 Nov 2025
Investors Don't See Light At End Of American Well Corporation's (NYSE:AMWL) Tunnel And Push Stock Down 27% - simplywall.st
Wed, 05 Nov 2025
Stifel Maintains American Well (AMWL) Hold Recommendation - Nasdaq
Tue, 04 Nov 2025
American Well Corp (AMWL) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Wed, 08 Oct 2025
American Well: Trading At Half Of Net Cash, It Has Optionality (NYSE:AMWL) - Seeking Alpha
Thu, 04 Sep 2025
Gotlib, American Well Corp president, sells $32k in AMWL stock - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 15 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 5.4 (%) |
| Held by Institutions | 43.6 (%) |
| Shares Short | 152 (K) |
| Shares Short P.Month | 142 (K) |
| EPS | -7.2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 15.61 |
| Profit Margin | -42.8 % |
| Operating Margin | -52.2 % |
| Return on Assets (ttm) | -15.2 % |
| Return on Equity (ttm) | -37.1 % |
| Qtrly Rev. Growth | -7.9 % |
| Gross Profit (p.s.) | 9.46 |
| Sales Per Share | 18 |
| EBITDA (p.s.) | -4.65 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -62 (M) |
| Levered Free Cash Flow | 6 (M) |
| PE Ratio | -0.66 |
| PEG Ratio | 0 |
| Price to Book value | 0.3 |
| Price to Sales | 0.26 |
| Price to Cash Flow | -1.12 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|